99-19870. Medical Devices; Device Use Safety: Incorporating Human Factors in Risk Management; Availability  

  • [Federal Register Volume 64, Number 148 (Tuesday, August 3, 1999)]
    [Notices]
    [Pages 42138-42139]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-19870]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 99D-2152]
    
    
    Medical Devices; Device Use Safety: Incorporating Human Factors 
    in Risk Management; Availability
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing the 
    availability of the draft guidance entitled ``Draft Guidance on Device 
    Use Safety: Incorporating Human Factors in Risk Management.'' This 
    draft guidance is neither final nor is it in effect at this time. This 
    draft guidance describes how to incorporate human factors techniques 
    and theory into risk management during the development of medical 
    devices. The draft guidance is intended to assist both reviewers of 
    premarket device submissions and manufacturers that develop devices. 
    The draft guidance is expected to decrease problems with the use of 
    medical devices that impact safety and effectiveness and help ensure 
    safer and more effective devices.
    
    DATES: Written comments concerning this draft guidance must be 
    submitted by November 1, 1999.
    
    ADDRESSES: See the SUPPLEMENTARY INFORMATION section for information on 
    electronic access to the draft guidance. Submit written requests for 
    single copies on a 3.5'' diskette of the draft guidance entitled 
    ``Draft Guidance on Device Use Safety: Incorporating Human Factors in 
    Risk Management'' to the Division of Small Manufacturers Assistance 
    (HFZ-220), Center for Devices and Radiological Health, Food and Drug 
    Administration, 1350 Piccard Dr., Rockville, MD 20850. Send two self-
    addressed adhesive labels to assist that office in processing your 
    request, or fax your request to 301-443-8818.
        Submit written comments on the draft guidance to the Dockets 
    Management Branch, (HFA-305), Food and Drug Administration, 5630 
    Fishers Lane, rm. 1061, Rockville, MD 20852.
    
    FOR FURTHER INFORMATION CONTACT: Ron D. Kaye, Center for Devices and 
    Radiological Health (HFZ-230), Food and Drug Administration, 1350 
    Piccard Dr., Rockville, MD 20850, 301-594-3265.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
        The draft guidance provides a suggested approach for integrating
    
    [[Page 42139]]
    
    human factors within risk management for medical device design and 
    development. It also contains an introduction to both risk management 
    and human factors and a discussion of how they are linked. The focus is 
    on reducing risks related specifically to the use of medical devices. 
    Human factors techniques are discussed in the context of management. 
    The draft guidance also suggests how human factors-risk management 
    efforts should be documented and included in premarket submissions.
        This draft guidance document represents the agency's current 
    thinking on applying human factors to new medical device design and 
    development to help ensure that use of a device will be safe and 
    effective. It does not create or confer any rights for or on any person 
    and does not operate to bind FDA or the public. An alternative approach 
    may be used if such approach satisfies the applicable statute, 
    regulations, or both.
        The agency has adopted good guidance practices (GGP's), which set 
    forth the agency's policies and procedures for the development, 
    issuance, and use of guidance documents (62 FR 8961, February 27, 
    1997). This draft guidance document is issued as a Level 1 guidance 
    consistent with GGP's.
    
    II. Electronic Access
    
        In order to receive ``Draft Guidance on Device Use Safety: 
    Incorporating Human Factors in Risk Management'' via your fax machine, 
    call the CDRH Facts-On-Demand (FOD) system at 800-899-0381 or 301-827-
    0111 from a touch tone telephone. At the first voice prompt press 1 to 
    access DSMA Facts, at second voice prompt press 2, and then enter the 
    document number (1497) followed by the pound sign (#). Then follow the 
    remaining voice prompts to complete your request.
        Persons interested in obtaining a copy of the draft guidance may 
    also do so using the World Wide Web (WWW). CDRH maintains an entry on 
    the WWW for easy access to information including text, graphics, and 
    files that may be downloaded to a personal computer with access to the 
    WWW. Updated on a regular basis, the CDRH home page includes the 
    ``Draft Guidance on Device Use Safety: Incorporating Human Factors in 
    Risk Management,'' device safety alerts, Federal Register reprints, 
    information on premarket submissions (including lists of approved 
    applications and manufacturers' addresses), small manufacturers' 
    assistance, information on video conferencing and electronic 
    submissions, mammography matters, and other device-oriented 
    information. The CDRH home page may be accessed at ``http://
    www.fda.gov/cdrh''. The ``Draft Guidance on Device Use Safety: 
    Incorporating Human Factors in Risk Management'' will be available at 
    ``http://www.fda.gov/cdrh/HumanFactors.html''.
    
    III. Comments
    
        Interested persons may submit written comments regarding this draft 
    guidance. Two copies of any comments are to be submitted to Dockets 
    Management Branch (address above), except that individuals may submit 
    one copy. Comments should be identified with the docket number found in 
    brackets in the heading of this document. A copy of the draft guidance 
    and received comments are available for public examination in the 
    Dockets Management Branch between 9 a.m. and 4 p.m., Monday through 
    Friday.
    
        Dated: July 20, 1999.
    Linda S. Kahan,
    Deputy Director for Regulations Policy, Center for Devices and 
    Radiological Health.
    [FR Doc. 99-19870 Filed 8-2-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
08/03/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-19870
Dates:
Written comments concerning this draft guidance must be submitted by November 1, 1999.
Pages:
42138-42139 (2 pages)
Docket Numbers:
Docket No. 99D-2152
PDF File:
99-19870.pdf